213 related articles for article (PubMed ID: 10657898)
1. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
2. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
3. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
4. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
6. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.
Hata K; Nishijima K; Mizuguchi J
Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
8. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
9. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes.
Velasco-Miguel S; Buckbinder L; Jean P; Gelbert L; Talbott R; Laidlaw J; Seizinger B; Kley N
Oncogene; 1999 Jan; 18(1):127-37. PubMed ID: 9926927
[TBL] [Abstract][Full Text] [Related]
10. Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.
Duriez C; Falette N; Cortes U; Moyret-Lalle C; Puisieux A
Oncogene; 2000 May; 19(20):2461-4. PubMed ID: 10828889
[TBL] [Abstract][Full Text] [Related]
11. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
12. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
[TBL] [Abstract][Full Text] [Related]
13. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
14. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
15. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
Micheli L; Ceccarelli M; Farioli-Vecchioli S; Tirone F
J Cell Physiol; 2015 Dec; 230(12):2881-90. PubMed ID: 25967096
[TBL] [Abstract][Full Text] [Related]
16. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
17. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
Cheung KJ; Bush JA; Jia W; Li G
Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
20. Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage.
Zhan Q
Mutat Res; 2005 Jan; 569(1-2):133-43. PubMed ID: 15603758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]